1 IRCCS San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milan, Italy
2 Istituto di Ematologia, Fondazione Polclinico Universitario A. Gemelli, Universita’ Cattolica del Sacro Cuore, Roma, Italy
3 Department of Pediatrics, Section Immunology, Hematology and Stem Cell Transplantation, Leiden University Medical Center, Leiden, Netherlands
4 Division of Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, USA
Book Affiliations
1 Spanish Bone Marrow Donor Registry, Josep Carreras Foundation and Leukemia Research Institute, Catalunya, Barcelona, Spain
2 Hematology Unit, IRCCS Giannina Gaslini, Geneva, Switzerland
3 Department of Hematology, Pierre and Marie Curie University, Paris, France
4 Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppend, Hamburg, Germany
Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is now considered a clinical therapeutic option in patients candidate to allo-HSCT.